222 related articles for article (PubMed ID: 24625428)
1. How to select the right patients for focal therapy of prostate cancer?
Passoni NM; Polascik TJ
Curr Opin Urol; 2014 May; 24(3):203-8. PubMed ID: 24625428
[TBL] [Abstract][Full Text] [Related]
2. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
3. Targeted prostate biopsy and MR-guided therapy for prostate cancer.
Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
Abdom Radiol (NY); 2016 May; 41(5):877-88. PubMed ID: 26907717
[TBL] [Abstract][Full Text] [Related]
4. Biopsy strategies for selecting patients for focal therapy for prostate cancer.
Kanthabalan A; Emberton M; Ahmed HU
Curr Opin Urol; 2014 May; 24(3):209-17. PubMed ID: 24670871
[TBL] [Abstract][Full Text] [Related]
5. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
6. Imaging modalities in focal therapy: patient selection, treatment guidance, and follow-up.
Muller BG; van den Bos W; Pinto PA; de la Rosette JJ
Curr Opin Urol; 2014 May; 24(3):218-24. PubMed ID: 24637316
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer multifocality, the index lesion, and the microenvironment.
Tourinho-Barbosa RR; de la Rosette J; Sanchez-Salas R
Curr Opin Urol; 2018 Nov; 28(6):499-505. PubMed ID: 30138121
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer: state of the art imaging and focal treatment.
Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
Clin Radiol; 2017 Aug; 72(8):665-679. PubMed ID: 28385253
[TBL] [Abstract][Full Text] [Related]
9. What is still needed to make focal therapy an accepted segment of standard therapy?
van den Bos W; Muller BG; Ehdaie B; Scardino P; de la Rosette JJ
Curr Opin Urol; 2014 May; 24(3):247-55. PubMed ID: 24637317
[TBL] [Abstract][Full Text] [Related]
10. Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future.
Arcot R; Polascik TJ
Urol Clin North Am; 2022 Feb; 49(1):129-152. PubMed ID: 34776047
[TBL] [Abstract][Full Text] [Related]
11. Active surveillance for prostate cancer: can we modernize contemporary protocols to improve patient selection and outcomes in the focal therapy era?
Tay KJ; Mendez M; Moul JW; Polascik TJ
Curr Opin Urol; 2015 May; 25(3):185-90. PubMed ID: 25768694
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer tumour features on template prostate-mapping biopsies: implications for focal therapy.
Singh PB; Anele C; Dalton E; Barbouti O; Stevens D; Gurung P; Arya M; Jameson C; Freeman A; Emberton M; Ahmed HU
Eur Urol; 2014 Jul; 66(1):12-9. PubMed ID: 24207133
[TBL] [Abstract][Full Text] [Related]
13. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy.
Komai Y; Numao N; Yoshida S; Matsuoka Y; Nakanishi Y; Ishii C; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
J Urol; 2013 Sep; 190(3):867-73. PubMed ID: 23542406
[TBL] [Abstract][Full Text] [Related]
14. Intraprostatic targeting.
Ukimura O; Faber K; Gill IS
Curr Opin Urol; 2012 Mar; 22(2):97-103. PubMed ID: 22249373
[TBL] [Abstract][Full Text] [Related]
15. Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project.
Muller BG; van den Bos W; Brausi M; Cornud F; Gontero P; Kirkham A; Pinto PA; Polascik TJ; Rastinehad AR; de Reijke TM; de la Rosette JJ; Ukimura O; Villers A; Walz J; Wijkstra H; Marberger M
BJU Int; 2014 Nov; 114(5):698-707. PubMed ID: 24180365
[TBL] [Abstract][Full Text] [Related]
16. New advances in focal therapy for early stage prostate cancer.
Tay KJ; Schulman AA; Sze C; Tsivian E; Polascik TJ
Expert Rev Anticancer Ther; 2017 Aug; 17(8):737-743. PubMed ID: 28635336
[TBL] [Abstract][Full Text] [Related]
17. Focal Ablation of Early-Stage Prostate Cancer: Candidate Selection, Treatment Guidance, and Assessment of Outcome.
Edison E; Tariq Shah T; Ahmed HU
Urol Clin North Am; 2017 Nov; 44(4):575-585. PubMed ID: 29107274
[TBL] [Abstract][Full Text] [Related]
18. Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study.
Hoeks CM; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Roobol MJ; Bul M; Hambrock T; Witjes JA; Fütterer JJ; Hulsbergen-van de Kaa CA; Barentsz JO
Invest Radiol; 2014 Mar; 49(3):165-72. PubMed ID: 24220253
[TBL] [Abstract][Full Text] [Related]
19. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience.
Barzell WE; Melamed MR
Urology; 2007 Dec; 70(6 Suppl):27-35. PubMed ID: 18194708
[TBL] [Abstract][Full Text] [Related]
20. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
Eggener SE; Scardino PT; Carroll PR; Zelefsky MJ; Sartor O; Hricak H; Wheeler TM; Fine SW; Trachtenberg J; Rubin MA; Ohori M; Kuroiwa K; Rossignol M; Abenhaim L;
J Urol; 2007 Dec; 178(6):2260-7. PubMed ID: 17936815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
